These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

168 related items for PubMed ID: 933973

  • 1. Single-dose evaluation of a new enteric-coated aspirin preparation.
    Paull P, Day R, Graham G, Champion D.
    Med J Aust; 1976 Apr 24; 1(17):617-9. PubMed ID: 933973
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Interaction of omeprazole with enteric-coated salicylate tablets.
    Nefesoglu FZ, Ayanoglu-Dülger G, Ulusoy NB, Imeryüz N.
    Int J Clin Pharmacol Ther; 1998 Oct 24; 36(10):549-53. PubMed ID: 9799060
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Comparative bioavailability of aspirin from buffered, enteric-coated and plain preparations.
    Latini R, Cerletti C, de Gaetano G, Dejana E, Galletti F, Urso R, Marzot M.
    Int J Clin Pharmacol Ther Toxicol; 1986 Jun 24; 24(6):313-8. PubMed ID: 3733281
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Comparison of kaolin-pectin and activated charcoal for inhibition of aspirin absorption.
    Juhl RP.
    Am J Hosp Pharm; 1979 Aug 24; 36(8):1097-8. PubMed ID: 484570
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [Analgesics; the use of aspirin in dogs; effects of tablet type and food intake on plasma salicylate level].
    Nap RC, Breen DJ, Lam TJ, Peters IO, Willemsen A, De Bruyne JJ.
    Tijdschr Diergeneeskd; 1993 Jul 15; 118(13):439-42. PubMed ID: 8346511
    [Abstract] [Full Text] [Related]

  • 12. Effect of cimetidine on bioavailability of enteric-coated aspirin tablets.
    Paton TW, Walker SE, Leung FY, Little AH.
    Clin Pharm; 1983 Jul 15; 2(2):165-6. PubMed ID: 6883946
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. The effects of enteric coating of aspirin tablets on occult gastrointestinal blood loss.
    Howe GB, Champion GD, Corrigan AB, Hewson J, Haski A, Day RO, Paull PD, Graham GG.
    Aust N Z J Med; 1977 Dec 15; 7(6):600-4. PubMed ID: 350214
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Comparative bioavailability of sustained-release and uncoated aspirin tablets.
    Karahalios WJ, Sawyer WT, Rittase RA, Maynard SA.
    Am J Hosp Pharm; 1981 Nov 15; 38(11):1754-6. PubMed ID: 7304632
    [Abstract] [Full Text] [Related]

  • 18. Suprofen sustained release kinetics in healthy male volunteers. 1st communication: a single dose open crossover bioavailability study of suprofen sustained release tablets versus capsules.
    Michos N, Zulliger HW, Barkworth MF, Johnson KJ, Rehm KD, Töberich H, Klein G.
    Arzneimittelforschung; 1986 Jun 15; 36(6):941-8. PubMed ID: 3741528
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.